Genlabs Cerebrolysin 60mg is a peptide-based neurotrophic formulation composed of low–molecular weight peptides and free amino acids derived from purified porcine brain proteins. It is designed to mimic the activity of naturally occurring neurotrophic factors involved in brain development, maintenance, and repair.

Cerebrolysin has been studied for decades in neurological and neurodegenerative conditions and is primarily used in clinical and research settings to support brain function, cognitive recovery, and neuronal protection.

How It Works?

Genlabs Cerebrolysin 60mg acts by supporting multiple biological pathways involved in brain health rather than targeting a single receptor or mechanism. Its peptides are capable of crossing the blood–brain barrier, where they influence neuronal metabolism and survival.

Dosage :

Reconstitute: Add 3.0 mL bacteriostatic water to the 60 mg vial → 20 mg/mL concentration.

Typical daily range: 20–32 mg once or twice daily (gradual titration over 3–4 weeks).

Easy measuring: At 20 mg/mL, 1 unit = 0.01 mL = 200 mcg (0.2 mg) on a U-100 insulin syringe.

Storage: Lyophilized: After reconstitution, refrigerate at 2–8 °C (36–46 °F) and use within 7 days.

Benefits :

Cerebrolysin has been studied and used for a variety of neurological applications, with reported benefits including:

• Support for cognitive function (memory, attention, processing speed)
• Enhanced neuroplasticity and learning capacity
• Improved recovery following stroke or traumatic brain injury (TBI)
• Potential slowing of cognitive decline in neurodegenerative conditions
• Support for overall brain metabolism and resilience

Results may vary depending on the individual, condition, and treatment protocol.

Side Effects :

Cerebrolysin is generally well tolerated when used appropriately, but side effects can occur.

• Injection site irritation or pain
• Headache or dizziness
• Fatigue or restlessness
• Nausea or gastrointestinal discomfort
• Rarely, allergic reactions

Most side effects are mild and transient. Serious adverse effects are uncommon when administered correctly under medical supervision.

Conclusion :

Genlabs Cerebrolysin 60 mg is a well-studied neuropeptide formulation with a unique, multi-pathway approach to supporting brain health and neurological recovery. By mimicking natural neurotrophic factors, it plays a role in neuroprotection, synaptic plasticity, and neuronal repair. While it shows promise across a range of neurological applications, its use should be guided by qualified healthcare professionals, particularly with regard to dosing and administration.